Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations.
We describe and functionally characterize six mutations of the acetylcholine receptor (AChR) epsilon subunit gene in three congenital myasthenic syndrome patients. Endplate studies demonstrated severe endplate AChR deficiency, dispersed endplate regions and well preserved junctional folds in all three patients. Electrophysiologic studies were consistent with expression of the fetal gamma-AChR at the endplates in one patient, prolongation of some channel events in another and gamma-AChR expression as well as some shorter than normal channel events in still another. Genetic analysis revealed two recessive and heteroallelic epsilon subunit gene mutations in each patient. One mutation in each (epsilonC190T [epsilon R64X], epsilon 127ins5 and epsilon 553del 7) generates a nonsense codon that predicts truncation of the epsilon subunit in its N-terminal, extracellular domain; and one mutation in each generates a missense codon (epsilon R147L, epsilon P245L and epsilon R311W). None of the mutations was detected in 100 controls. Expression studies in HEK cells indicate that the three nonsense mutations are null mutations and that surface expression of AChRs harboring the missense mutations is significantly reduced. Kinetic analysis of AChRs harboring the missense mutations show that epsilon R147L is kinetically benign, epsilon P245L prolongs burst open duration 2-fold by slowing the rate of channel closing and epsilon R311W shortens burst duration 2-fold by slowing the rate of channel opening and speeding the rate of ACh dissociation. The modest changes in activation kinetics are probably overshadowed by reduced expression of the missense mutations. The consequences of the endplate AChR deficiency are mitigated by persistent expression of gamma-AChR, changes in the release of transmitter quanta and appearance of multiple endplate regions on the muscle fiber.
Ohno
K
K
Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Quiram
P A
PA
Milone
M
M
Wang
H L
HL
Harper
M C
MC
Pruitt
J N
JN
Brengman
J M
JM
Pao
L
L
Fischbeck
K H
KH
Crawford
T O
TO
Sine
S M
SM
Engel
A G
AG
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials; D000328:Adult; D000483:Alleles; D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D002648:Child; D002675:Child, Preschool; D004594:Electrophysiology; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009045:Motor Endplate / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D009154:Mutation; D009157:Myasthenia Gravis / Q000151:congenital / Q000235:genetics*; D018408:Patch-Clamp Techniques; D051381:Rats; D011950:Receptors, Cholinergic / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D014162:Transfection
D011950:Receptors, Cholinergic; D011994:Recombinant Proteins; D000109:Acetylcholine